Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Annexin Pharmaceuticals AB (publ)

Closing information (x1000 NOK)

Closing information 2024/12 2023/12 2022/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 0 Equal arrow 0 More Arrow 2
Earnings before taxes -51,825 More Arrow -44,628 More Arrow -38,523
EBITDA -52,060 More Arrow -44,752 More Arrow -38,521
Total assets 19,632 More Arrow 27,112 More Arrow 34,695
Current assets 17,925 More Arrow 25,240 More Arrow 31,830
Current liabilities 5,490 More Arrow 8,053 Less Arrow 6,173
Equity capital 14,142 More Arrow 19,059 More Arrow 28,522
- share capital 9,097 Less Arrow 5,811 Less Arrow 2,419
Employees (average) 4 Equal arrow 4 More Arrow 5

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 72.0% Less Arrow 70.3% More Arrow 82.2%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -264.0% More Arrow -164.6% More Arrow -111.0%
Current ratio 326.5% Less Arrow 313.4% More Arrow 515.6%
Return on equity (ROE) -366.5% More Arrow -234.2% More Arrow -135.1%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 Less Arrow -1 More Arrow 0
Chg. No. of employees % 0% Less Arrow -20% More Arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.